Results 201 to 210 of about 901,832 (266)

Early Clinical and Cerebrospinal Fluid Predictors of 1‐Year Recurrence in Autoimmune GFAP Astrocytopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong, Yuping Xiao, Yuhan Wu, Ziyuan Huang, Weishan Liang, Li Xiao, Yaqing Shu, Tingting Lu, Yanyu Chang, Wei Qiu, Yuge Wang   +10 more
wiley   +1 more source

Normalization of CEA, CA15-3, and CA27-29 Tumor Markers Following Single Lung Transplant in a Patient With a History of Early-Stage Breast Cancer and Idiopathic Pulmonary Fibrosis: A Case Report. [PDF]

Cancer Rep (Hoboken)
Chamorro Y, Vogel CL, Sandoval-Leon AC.
europepmc   +1 more source

Safety of Clomiphene Citrate and Its Impact on Serum Tumor Markers in Hypogonadal Testicular Cancer Patients After Chemotherapy. [PDF]

Cureus
Wren J, Myre B, Halpern JA, Panken E, Bennett NE, Brannigan RE.   +5 more
europepmc   +1 more source

Correlation between laparoscopic radical resection and tumor markers in peritoneal irrigation fluid. [PDF]

World J Gastrointest Surg
Zhou JF, Qiu W, Chen JS, Yan BQ, Feng XH, Xu MZ, Yang JP.   +6 more
europepmc   +1 more source

Abnormal expression of miR-22-5p in breast cancer patients and its correlation with 18 F-FDG PET/CT features and serum-related tumor markers. [PDF]

World J Surg Oncol
Hu T, Tang P, Wu X.
europepmc   +1 more source

Tumor markers and multimodal magnetic resonance imaging in predicting rectal cancer stage and differentiation. [PDF]

World J Gastrointest Oncol
Wang P, Han J, Zhao WN, Wu F, Zhang SH, Huang YJ.   +5 more
europepmc   +1 more source

Association between Helicobacter pylori infection and the types of tumor markers among Yemeni gastric cancer patients: a case-control study. [PDF]

BMC Res Notes
Abdulmughni GT, Al-Nabhi AS, Al-Sheibani AA, Al-Haidary NM, Othman AM, Jahzar KH, Al-Hnhna AA.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tumor Markers in Neuroendocrine Tumors

Digestion, 2000
Most neuroendocrine tumors produce and secrete a multitude of peptide hormones and amines. Some of these substances cause a specific clinical syndrome: carcinoid, Zollinger-Ellison, hyperglycemic, glucagonoma and WDHA syndrome. Specific markers for these syndromes are basal and/or stimulated levels of urinary 5-HIAA, serum or plasma gastrin, insulin ...
K, Oberg, E T, Janson, B, Eriksson
openaire   +3 more sources

Gynecologic tumor markers

Seminars in Surgical Oncology, 1990
AbstractThe advent of monoclonal technology has increased the potential utility of antibody‐dependent tumor marker assays in gynecologic oncology. The availability of unlimited quantities of several pure monoclonal antibodies directed against novel epitopes on tumor‐associated antigens has permitted development of highly sensitive assays for serum ...
G J, Olt, A, Berchuck, R C, Bast
openaire   +2 more sources